Introduction {#sec1}
============

A right anterior minithoracotomy allows entry to the thoracic cavity without splitting the sternum and has been adopted by different cardiac surgery centres to perform minimally invasive aortic valve replacement with very good results \[[@cit0001]\]. Reports describing the pulmonary function of patients after conventional or minimally invasive cardiac surgery are infrequent \[[@cit0002], [@cit0003]\].

Aim {#sec2}
===

The aim of this study is to compare pulmonary function in patients who underwent elective aortic valve replacement surgery through a right anterior minithoracotomy (RT-AVR) with the results from a control group for which aortic valve replacement was performed by a standard median sternotomy approach (AVR).

Material and methods {#sec3}
====================

Study design {#sec3.1}
------------

The study was performed in accordance with the Declaration of Helsinki and with the consensus guidelines expressed by the STROBE statement \[[@cit0004]\]. Approval from the Institutional Review Board and informed consent from patients were obtained and analysis of patients who had undergone aortic valve replacement surgery was conducted. It was an observational study of 221 consecutive patients who underwent RT-AVR and 316 who underwent AVR surgery between January 2011 and December 2014 at our institution.

In this study, we focused on respiratory function after aortic valve replacement using both techniques. All the data, including preoperative, in-hospital and post-discharge outcomes were prospectively collected. Patients eligible for study enrolment were those who required isolated aortic valve replacement. We excluded patients who had undergone redo surgery, aortic valve surgery with concomitant procedures, emergency operations due to infective endocarditis and patients with a left ventricle ejection fraction below 30%. In our department those higher risk patients are preferentially operated on using the conventional median sternotomy. Contraindication for RT-AVR surgery were calcifications of the ascending aorta, right pleural adhesions and expected difficult access to the aortic valve, based on preoperative computed tomography, when more than half of the diameter of the ascending aorta was positioned on the left of the right sternal border \[[@cit0001]\]. To obtain two comparable study groups, propensity score matching (PSM) was used to alleviate differences in preoperative patient characteristics.

Clinical parameters and perioperative events {#sec3.2}
--------------------------------------------

We analysed preoperative patients' characteristics, perioperative results, and respiratory function, which was studied based on spirometry examinations which were performed preoperatively (baseline values), on the seventh postoperative day, then after 1 and 3 months of follow-up. Analysed spirometry parameters were vital capacity (VC), forced expiratory volume in the first second (FEV~1~) and total lung capacity (TLC). The baseline data are expressed as a percentage of predicted values. The follow-up data are presented as a percentage of preoperative values.

The time of discharge from the intensive care unit (ICU) or hospital was determined by medical judgment and the patient's suitability for discharge \[[@cit0005]\].

Hospital mortality was defined as death for any reason that occurred within 30 days of surgery or during the same hospitalisation period if it was longer than 30 days \[[@cit0006]\]. Predicted hospital mortality was estimated with EuroSCORE II and calculated using the online calculator (<http://www.euroscore.org/calc.html>). Prolonged ventilation time indicated the necessity to use mechanical lung ventilation for a period longer than 24 h.

Surgery {#sec3.3}
-------

A detailed description of the surgical technique for RT-AVR surgery has already been presented \[[@cit0001], [@cit0006]\]. For preoperative planning of the RT-AVR surgery, patients underwent computed tomography imaging (Siemens Healthcare, Erlangen, Germany) \[[@cit0006]\]. A double lumen tracheal tube was used to allow for single lung ventilation. A cardiopulmonary bypass (CPB) was established with cannulation of the femoral vessels. The chest was entered through a 6 cm right anterior minithoracotomy in the third intercostal space. At the end of the surgical procedure, the double lumen tracheal tube was removed and the patient was re-intubated with a single lumen tracheal tube.

The pain management protocol was the same after conventional AVR surgery through median sternotomy and after minimally invasive RT-AVR surgery, and included metamizol (Pyralgin) 4 × 1.25 g *i.v.* and oxycodone hydrochloride (Oxycontin) 2 × 10--20 mg *p.o.* given daily during the postoperative period.

Statistical analysis {#sec3.4}
--------------------

Mean and standard deviation were used to report continuous variables, and counts with percentages to report categorical variables. The Mann-Whitney test was used to compare two independent groups of continuous variables, and for two dependent groups, the Wilcoxon signed-rank test was used. The Fisher exact test was used to compare two independent groups of categorical variables, and for two dependent groups the McNemar test was used.

A linear median regression was performed to analyse the association between the dependent variable and multiple independent variables. The estimated regression coefficients describe the change in the median of the dependent variable corresponding to a unit change in the independent variable with 95% confidence intervals (CI) \[[@cit0007]\]. In this model, the dependent variables were values of FEV~1~, TLC and VC expressed as percentage change from baseline values 1 week and 3 months after surgery. The surgical technique, age, sex, presence of chronic obstructive pulmonary disease (COPD) and prolonged CPB time (\> 120 min) were independent variables in the model.

The matched data set was constructed using propensity scores (PS). The PS were taken as linear predictor scores from the logistic regression model. The model included the following clinical variables: sex, age, age \> 80 years, body mass index, body mass index \> 25 kg/m^2^, bicuspid aortic valve, aortic stenosis, aortic valve area, haemoglobin concentration before surgery, haemodialysis, renal insufficiency, diabetes, COPD, EF \> 40%, hypertension, coronary artery disease, peripheral vascular disease, cerebrovascular disease, history of atrial fibrillation, NYHA class III or IV, history of myocardial infarction, and EuroSCORE II. Variables were selected before model estimation, and no statistical variable selection procedures were used. For each RT-AVR case one AVR case was paired, unless it was outside the calliper (equal to 0.25 of the standard deviation of the PS). Within the calliper we used optimal matching. The quality of matching was judged by the standardized differences.

All statistical analyses were performed using R 3.0 \[[@cit0008]\].

Results {#sec4}
=======

After PSM there were 212 RT-AVR and 212 AVR patients finally included in the study and control groups respectively. There were no statistically significant differences between the study groups after PSM in terms of patient demographics and preoperative patient characteristics ([Tab. I](#t0001){ref-type="table"}).

###### 

Demographic and preoperative characteristics of patients after propensity score matching

  Characteristics                             RT-AVR group (*N* = 212)   AVR group (*N* = 212)   *P*-value   Standardized differences
  ------------------------------------------- -------------------------- ----------------------- ----------- --------------------------
  Males, % (*n*)                              57.5 (122)                 54.7 (116)              0.565       0.057
  Age \[years\]                               68.1 ±10.3                 68.6 ±10.5              0.559       0.050
  Age \> 80 years, % (*n*)                    4.7 (10)                   6.1 (13)                0.458       0.062
  Body mass index \[kg/m^2^\]                 27.0 ±5.4                  27.3 ±7.1               0.912       0.045
  Body mass index \> 25 kg/m^2^, % (*n*)      62.7 (133)                 60.8 (129)              0.707       0.039
  Bicuspid aortic valve, % (*n*)              32.5 (69)                  34.0 (72)               0.757       0.030
  Aortic stenosis, % (*n*)                    72.2 (153)                 71.2 (151)              0.821       0.021
  Aortic valve area \[cm^2^\]                 0.7 ±0.4                   0.7 ±0.3                0.716       0.032
  Hb (a day before surgery) \[g/dl\]          13.6 ±2.7                  13.4 ±2.9               0.430       0.064
  Haemodialysis, % (*n*)                      0.5 (1)                    0.9 (2)                 0.773       0.056
  Renal insufficiency, % (*n*)                9.9 (21)                   9.4 (20)                0.879       0.016
  Diabetes, % (*n*)                           13.7 (29)                  15.1 (32)               0.666       0.040
  COPD, % (*n*)                               7.5 (16)                   7.1 (15)                0.862       0.018
  EF (%)                                      48.6 ±12.3                 47.7 ±14.6              0.304       0.065
  EF \> 40%, % (*n*)                          76.4 (162)                 75.0 (159)              0.678       0.033
  Hypertension, % (*n*)                       46.2 (98)                  45.8 (97)               0.923       0.009
  Coronary artery disease, % (*n*)            13.7 (29)                  12.7 (27)               0.773       0.028
  Peripheral vascular disease, % (*n*)        14.6 (31)                  14.2 (30)               0.889       0.013
  Cerebrovascular disease, % (*n*)            10.8 (23)                  9.9 (21)                0.763       0.031
  History of atrial fibrillation, % (*n*)     12.3 (26)                  10.4 (22)               0.522       0.059
  NYHA class III or IV, % (*n*)               25.9 (55)                  25.0 (53)               0.833       0.022
  History of myocardial infarction, % (*n*)   11.8 (25)                  10.8 (23)               0.768       0.030
  Predicted mortality, Euro SCORE II, %       3.2 ±1.1                   3.1 ±1.6                0.298       0.029

Continuous variables are described by mean ± standard deviation (SD), categorical variables are shown as a percentage, *n* -- number of patients, AVR -- aortic valve replacement through sternotomy, COPD -- chronic obstructive pulmonary disease, CPB -- cardiopulmonary bypass, EF -- ejection fraction, EuroSCORE II -- European System for Cardiac Operative Risk Evaluation, Hb -- haemoglobin concentration, NYHA -- New York Heart Association, RT-AVR -- minimally invasive aortic valve replacement through right minithoracotomy.

Hospital mortality and predicted mortality were 1.4% vs. 1.9% (*p* = 0.777) and 3.2 ±1.1% vs. 3.1 ±1.6% (*p* = 0.298) for RT-AVR vs. AVR groups respectively. Mechanical ventilation time in ICU was 7.3 ±3.9 h for RT-AVR and 9.6 ±5.5 h for AVR patients (*p* \< 0.001). More patients in the AVR group required mechanical ventilation for a period of over 24 h (7.5% vs. 2.8%, *p* = 0.035). Chest tube drainage during the first 24 h after surgery was 352.7 ±249.1 ml in the RT-AVR patients and 523.8 ±325.3 ml in AVR patients (*p* \< 0.001). The CPB time and aorta cross clamp time were longer for RT-AVR patients (110.8 ±25.0 vs. 97.3 ±19.1 min, *p* \< 0.001 and 78.3 ±13.5 vs. 62.9 ±13.5 min, *p* \< 0.001). The CPB time longer than 120 min was present in 36.3% of RT-AVR and 8.5% of AVR patients (*p* \< 0.001). The ICU and hospital stays were 1.3 ±1.2 vs. 2.6 ±2.8 days (*p* \< 0.001) and 5.7 ±1.6 vs. 8.5 ±4.3 days (*p* \< 0.001) in RT-AVR vs. AVR patients respectively.

There was no difference in mean values of baseline spirometry parameters expressed as percentage of predicted values between groups. One week and 1 month after surgery, all spirometry parameters were reduced in comparison to the baseline values in both RT-AVR and AVR groups. The pulmonary function test results were statistically significantly higher in the RT-AVR group than the AVR group.

Three months after surgery, all spirometry parameters were still reduced and had not returned to preoperative values in either the RT-AVR or AVR group. However, the difference in spirometry values was no longer statistically significant between RT-AVR and AVR groups ([Tab. II](#t0002){ref-type="table"}).

###### 

Spirometry parameters of patients after minimally invasive and conventional aortic valve replacement

  Characteristics          Minimally invasive (RT-AVR group) (*N* = 212)   Median sternotomy (AVR group) (*N* = 212)   *P*-value
  ------------------------ ----------------------------------------------- ------------------------------------------- -----------
  FEV~1~ baseline values   94.7 ±9.9                                       92.8 ±14.1                                  0.361
  FEV~1~ after 1 week      79.5 ±10.1                                      74.0 ±11.3                                  \< 0.001
  FEV~1~ after 1 month     83.5 ±8.6                                       80.8 ±11.1                                  0.015
  FEV~1~ after 3 months    84.3 ±8.5                                       83.1 ±8.1                                   0.203
  VC baseline values       95.9 ±10.9                                      91.9 ±16.3                                  0.082
  VC after 1 week          64.8 ±8.8                                       51.5 ±11.1                                  \< 0.001
  VC after 1 month         84.2 ±9.1                                       78.6 ±10.5                                  \< 0.001
  VC after 3 months        87.2 ±7.9                                       86.2 ±8.2                                   0.110
  TLC baseline values      94.1 ±12.9                                      89.9 ±13.2                                  0.218
  TLC after 1 week         67.1 ±7.5                                       53.3 ±13.0                                  \< 0.001
  TLC after 1 month        85.6 ±9.1                                       74.5 ±13.7                                  \< 0.001
  TLC after 3 months       86.6 ±8.5                                       86.1 ±8.6                                   0.869

Baseline values of all patients are presented as a percentage of predicted values and expressed as mean ± standard deviation. Follow-up data are presented as a percentage of preoperative values and expressed as mean ± standard deviation. *N* -- number of patients, RT-AVR -- minimally invasive aortic valve replacement through right minithoracotomy, AVR -- aortic valve replacement through median sternotomy, VC -- vital capacity, FEV~1~ -- forced expiratory volume in the first second, TLC -- total lung capacity.

The linear median regression model shows that the surgical technique used for the RT-AVR group was associated with higher values of spirometry parameters obtained 1 week after surgery. The regression coefficient for the RT-AVR surgical technique in the model describing the change of FEV~1~ 1 week after surgery was 5.0 (*p* \< 0.001), which means that the FEV~1~ median value was 5.0 percentage points higher in the RT-AVR group after adjusting for sex, age, presence of COPD and prolonged CPB time. Three months after surgery, these results were no longer present. Presence of COPD was associated with lower values of spirometry parameters after surgery ([Tab. III](#t0003){ref-type="table"}).

###### 

Multivariable median regression analysis of forced expiratory volume in the first second changes that occurred 1 week and 3 months after surgery

  Parameter                          Regression coefficient   95% CI          *P*-value
  ---------------------------------- ------------------------ --------------- -----------
  FEV~1~ after 1 week:                                                        
   RT-AVR group                      5.0                      2.6; 7.4        \< 0.001
   Female sex                        0.0                      --2.0; 2.0      1.000
   Age                               0.0                      --0.7; 0.7      1.000
   COPD                              --14.0                   --18.4; --9.6   \< 0.001
   Prolonged CPB time (\> 120 min)   --1.0                    --4.1; 2.1      0.529
  FEV~1~ after 3 months:                                                      
   RT-AVR group                      0.2                      --1.9; 2.2      0.872
   Female sex                        0.1                      --2.0; 2.1      0.937
   Age                               --0.8                    --1.9; 0.2      0.113
   COPD                              --10.4                   --16.6; --4.3   0.001
   Prolonged CPB time (\> 120 min)   --0.3                    --3.1; 2.5      0.815

COPD -- chronic obstructive pulmonary disease, CPB -- cardiopulmonary bypass, FEV~1~ -- forced expiratory volume in the first second, RT-AVR -- minimally invasive aortic valve replacement through right minithoracotomy.

Discussion {#sec5}
==========

The main findings of our study were that the respiratory function was more impaired in the sternotomy group, and there was a statistically significant difference in the pulmonary status of the two groups 1 week after surgery. This would suggest that faster mobilisation and more efficient early recovery of pulmonary function are more likely for patients who have had minimally invasive RT-AVR surgery \[[@cit0003]\].

Other studies previously showed that less invasive surgical approaches to cardiac surgery have advantages over the standard median sternotomy in terms of postoperative pulmonary function and the recovery of pulmonary status \[[@cit0002], [@cit0003]\]. These reports presented similar results to our study. The patients who underwent RT-AVR surgery had less impaired postoperative respiratory function. This was probably due to their chest wall integrity being better preserved in comparison to patients who undergo a median sternotomy \[[@cit0003], [@cit0004]\].

According to our observations, more invasive surgery through a standard median sternotomy resulted in longer mechanical ventilation time than with a right minithoracotomy. Therefore, the ICU and hospital stay was significantly shorter in RT-AVR patients \[[@cit0009]\].

As could be expected, the pulmonary functional status indicated by spirometry examinations continued to improve steadily over the postoperative months \[[@cit0010]\]. The difference in pulmonary function between the groups disappeared between 1 and 3 months after the operation, and it can be assumed that in the later postoperative period pulmonary rehabilitation would be comparable in both the RT-AVR and AVR groups. Nevertheless, for as long as 3 months after surgery, neither the AVR nor the RT-AVR spirometry parameters returned to preoperative values. This demonstrates that the results of surgical trauma can impair pulmonary function for a significant length of time after surgery.

Using a minithoracotomy for surgical access makes the surgery more demanding, as the small thoracic working port results in more difficulties at every step of the aortic valve replacement procedure. This all requires additional time, which translates into longer aortic cross-clamping time and operation time. This observation confirms previous reports on minimally invasive heart valve surgery \[[@cit0011]\].

In our model of multivariable median regression analysis, minimally invasive RT-AVR surgery was a factor that had a strong influence on obtaining better spirometry parameters values early after surgery.

The minimally invasive RT-AVR surgery resulted in shorter ventilation time in ICU and less respiratory failure expressed by reduced incidence of prolonged mechanical ventilation time.

In the RT-AVR group, there was no instance of mediastinitis, but 2.8% of patients from the AVR group had mediastinitis and sternum instability requiring surgical treatment.

Postoperative chest tube drainage in patients undergoing RT-AVR was also statistically significantly lower. This could be a reflection of the reduced surgical trauma from a minithoracotomy compared to median sternotomy surgery \[[@cit0009]--[@cit0011]\]. Further studies should be continued to explain the relation between the extent of surgical trauma after cardiac surgical procedures and postoperative function of the respiratory system.

Limitations {#sec5.1}
-----------

There are several limitations of our study. The first is that it was not randomized, but a single-centre observational study, and thus the results we obtained should be explored further. Higher risk patients were excluded from the analysis, as in our department these patients are preferentially operated on with a conventional median sternotomy approach.

Secondly, the functional pulmonary status evaluation with spirometry examination was discontinued 3 months after surgery.

Finally, we did not perform postoperative pain analysis, which is an important factor that could have an influence on postoperative recovery and pulmonary functional status. Standardized postoperative pain evaluation was not included in the postoperative care protocol in our institution. Our subjective experience was that pain control following our protocol was equally efficient for both the conventional AVR and minimally invasive RT-AVR groups.

Conclusions {#sec6}
===========

To summarize, we can conclude that the less invasive, RT-AVR surgery is a safe procedure, which allows for a reduction in surgical trauma and positively influences pulmonary recovery especially in the early postoperative period, which leads to shortened ICU and hospital stays. In our personal opinion, it is justifiable to state that minimally invasive RT-AVR surgery could potentially be a better option for patients who have previously suffered from pulmonary disease (such as chronic obstructive pulmonary disease) and who are at higher risk of developing pulmonary dysfunction.
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